Trials / Completed
CompletedNCT01518699
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Effect of Ha44 Gel on the ECG in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers.
Detailed description
This study was a randomized, double-blind, placebo- and active-controlled, crossover study that evaluated the potential of Abametapir to prolong cardiac repolarization in healthy adult subjects (total of 57 subjects).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ha44 | Abametapir Lotion 0.74% |
| DRUG | Ha44 Placebo | Ha44 Vehicle Gel without Abametapir |
| DRUG | Moxifloxacin Placebo | Moxifloxacin Placebo |
| DRUG | Moxifloxacin | Moxifloxacin 400mg |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2012-01-26
- Last updated
- 2021-07-09
- Results posted
- 2021-07-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01518699. Inclusion in this directory is not an endorsement.